₹5.17
▲ +0.01 +0.19%
31 Jul 2026
BSE Listed · Pharmaceuticals
IBCWhat does IBC mean?
BSE · Securities under IBCThe company is in the insolvency process. Practical meaning: equity holders often recover little or nothing in resolution, so the exchange restricts price movement to stop speculative churn in a claim that may be extinguished.Criteria: Company admitted to the Corporate Insolvency Resolution Process under the Insolvency & Bankruptcy Code; placed under surveillance with restricted price movement.Exchange notice · 2026-04-21
Vivimed Labs Ltd. (532660)
Volume: 24,564Avg Vol 1W: 11,040Avg Vol 1M: 11,00152W Range:₹5₹27.99
Key Ratios
Checked 1h agoMarket Cap₹43 Cr
Current Price₹5.17
Previous Close₹5.16
High / Low (52w)₹27.99 / ₹5
Volume24,564
Avg Vol (1W)11,040
Avg Vol (1M)11,001
Stock P/E—
Book Value₹-29.98
Dividend Yield0%
ROE83.81%
ROA-23.42%
Revenue (TTM)—
Revenue Growth-22%
Profit Margin-252.12%
Total Debt₹64 Cr
Shares Outstanding8 Cr
Face Value₹2
EPS (TTM)₹0
P/B—
Debt / Equity0
50 DMA₹5.85
200 DMA—
Day change+0.19%
SurveillanceIBC
Price Chart
₹5.17▼ 80.50% · 1Y
2025-12-182026-07-31
20-day avg volume: 11K shares
Pros
- Healthy return on equity of 83.8%.
- Company is almost debt-free.
Cons
- Revenue fell 35% YoY.
- Company is loss-making at the latest annual result.
- Negative book value per share.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹29 Cr | ₹25 Cr | ₹37 Cr | ₹26 Cr | ₹21 Cr | ₹21 Cr | ₹16 Cr | ₹12 Cr |
| EBITDA | ₹-15 Cr | ₹-5 Cr | ₹-5 Cr | ₹-4 Cr | ₹-5 Cr | ₹-6 Cr | ₹-16 Cr | ₹-146 Cr |
| Net Profit | ₹-15 Cr | ₹-5 Cr | ₹-6 Cr | ₹-6 Cr | ₹-5 Cr | ₹-7 Cr | ₹-17 Cr | ₹-147 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹22 Cr | ₹34 Cr | ₹23 Cr | ₹121 Cr | ₹18 Cr | ₹19 Cr | ₹12 Cr | ₹8 Cr |
| EBITDA | ₹-5 Cr | ₹-7 Cr | ₹-3 Cr | ₹-29 Cr | ₹-5 Cr | ₹-6 Cr | ₹-16 Cr | ₹-141 Cr |
| Net Profit | ₹-5 Cr | ₹-7 Cr | ₹-4 Cr | ₹-32 Cr | ₹-5 Cr | ₹-7 Cr | ₹-17 Cr | ₹-142 Cr |
| EPS | — | — | — | -3.74 | — | — | — | — |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹2,394 Cr | ₹2,329 Cr | ₹2,210 Cr | ₹1,289 Cr | ₹1,266 Cr | ₹995 Cr | ₹951 Cr | ₹921 Cr |
| Total Liabilities | ₹1,155 Cr | ₹1,385 Cr | ₹1,375 Cr | ₹858 Cr | ₹902 Cr | ₹956 Cr | ₹956 Cr | ₹956 Cr |
| Equity | ₹1,239 Cr | ₹944 Cr | ₹835 Cr | ₹432 Cr | ₹364 Cr | ₹39 Cr | ₹-5 Cr | ₹-35 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹63 Cr | ₹437 Cr | ₹99 Cr | ₹542 Cr | ₹28 Cr | ₹35 Cr | ₹-24 Cr | ₹-2 Cr |
| Investing | ₹-164 Cr | ₹-89 Cr | ₹-196 Cr | ₹404 Cr | ₹-16 Cr | ₹-5 Cr | ₹28 Cr | ₹-5 Cr |
| Financing | ₹186 Cr | ₹-338 Cr | ₹72 Cr | ₹-1,015 Cr | ₹-10 Cr | ₹-34 Cr | ₹-6 Cr | ₹5 Cr |
| Free Cash Flow | ₹63 Cr | ₹437 Cr | ₹100 Cr | ₹542 Cr | ₹28 Cr | ₹35 Cr | ₹-24 Cr | ₹-2 Cr |
Shareholding
Promoter 7.57% Institutions 1.64% Public 90.78%
Efficiency & Working Capital
ROCE-27.9%
Interest Coverage-9.7
Dividend Payout—
Debtor Days233 d
Inventory Days184 d
Payable Days124 d
Cash Conversion Cycle293 d
Working Capital Days417 d
Shareholding Details
As of 2026-03-31
Promoter7.6%
FII1.6%
DII0%
Institutions1.6%
Public90.8%
Promoter Pledge15.2%
No. of Shareholders47,492
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 20.9% | 20.9% | 20.9% | 20.9% | 20.9% | 20.9% | 20.9% | 20.9% | 7.8% | 7.8% | 7.8% | 7.6% |
| FIIs | 1.6% | 1.6% | 1.6% | 1.6% | 1.6% | 1.6% | 1.6% | 1.6% | 1.6% | 1.6% | 1.6% | 1.6% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 77.4% | 77.4% | 77.4% | 77.4% | 77.4% | 77.4% | 77.4% | 77.4% | 90.6% | 90.6% | 90.6% | 90.8% |
| Promoter Pledge | 37.1% | 37.1% | 37.1% | 37.1% | 37.1% | 37.1% | 37.1% | 37.1% | 14.8% | 14.8% | 14.8% | 15.2% |
| No. of Shareholders | 49,503 | 49,038 | 49,027 | 49,016 | 49,012 | 49,003 | 49,005 | 48,957 | 48,928 | 48,925 | 49,221 | 47,492 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Kitara Piin 1102 | Public Shareholding | 9.4% | 77,66,387 |
| Varalwar Sandeep | Shareholding of Promoter and Promoter Group | 2.8% | 23,27,632 |
| William F Harvey | Public Shareholding | 1.7% | 13,69,840 |
| Sameer Mahendra Sampat | Public Shareholding | 1.6% | 13,59,165 |
| Subhash Varalwar | Shareholding of Promoter and Promoter Group | 1.6% | 13,49,154 |
| Amicorp Capital (mauritius) Limited | Public Shareholding | 1.5% | 12,19,298 |
| Ashish Bharatkumar Shah | Public Shareholding | 1.4% | 11,74,856 |
| Monarch Networth Finserve Private Limited | Public Shareholding | 1.2% | 10,31,000 |
| Jagat Foods Private Limited | Public Shareholding | 1.1% | 9,26,213 |
| Sheetal Varalwar | Shareholding of Promoter and Promoter Group | 0.8% | 6,85,185 |
| Manohar Rao Varalwar | Shareholding of Promoter and Promoter Group | 0.5% | 4,32,174 |
| Bbr Projects Private Limited | Shareholding of Promoter and Promoter Group | 0.5% | 4,34,450 |
| S Raghunandan | Shareholding of Promoter and Promoter Group | 0.4% | 3,17,500 |
| Madhavi Varalwar | Shareholding of Promoter and Promoter Group | 0.2% | 2,00,000 |
| Mamatha Gurnukar | Shareholding of Promoter and Promoter Group | 0.2% | 1,50,000 |
| Vijaykumar Varalwar | Shareholding of Promoter and Promoter Group | 0.2% | 1,50,000 |
| Neelima Vijaya Varalwar | Shareholding of Promoter and Promoter Group | 0.1% | 1,00,000 |
| Chandrashekharrao Sudigali | Shareholding of Promoter and Promoter Group | 0.1% | 50,095 |
| Varalwar Padma | Shareholding of Promoter and Promoter Group | 0% | 33,250 |
| Sujatha Varalwar | Shareholding of Promoter and Promoter Group | 0% | 25,995 |
| Vithabai Varalwar | Shareholding of Promoter and Promoter Group | 0% | 23,345 |
| Santosh Varalwar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Satish Gooty Agraharam | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Subhash Varalwar | 2,99,154 | 22.2% | 2026-03-31 |
| Varalwar Sandeep | 79,000 | 3.4% | 2026-03-31 |
| Manohar Rao Varalwar | 4,00,000 | 92.6% | 2026-03-31 |
| Mamatha Gurnukar | 1,50,000 | 100% | 2026-03-31 |
| Sujatha Varalwar | 25,000 | 96.2% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| V Manohar Rao | Chairman & Wholetime Director | 2025 |
| Santosh Varalwar | Executive Director & MD | 2025 |
| Sandeep Varalwar | Independent Non Exe. Director | 2025 |
| Aparna Bidarkar | Independent Non Exe. Director | 2025 |
| Subbarathnamma PalepU | Independent Non Exe. Director | 2025 |
| Jarugula Siva Prasad | Independent Non Exe. Director | 2025 |
| Yugandhar Kopparthi | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Speciality Chemicals | ₹0 Cr | 0% |
| Pharma | ₹108 Cr | 100% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹2 | 40 | 17 | 17 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-17 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | -84 | 1 | 0 | 3 | -46 | -126 |
| 2025 | -94 | 1 | 0 | 0 | -46 | -138 |
| 2025 | 5 | 0 | 0 | 3 | 0 | 7 |
Insider / Designated-Person Trades
9 recent disclosure(s)
Santosh VaralwarInvoke · 12,854
SANTOSH VARALWARDisposal · 8,44,542
Sujatha VaralwarInvoke · 15,00,000
Manohar Rao VaralwarInvoke · 2,60,000
Vithabai VaralwarInvoke · 9,50,000
B B R PROJECTS PRIVATE LIMITEDInvoke · 4,31,000
Company Information
🌐 www.vivimedlabs.com ↗
📍 Plot No 78-A, Kolhar Industrial Area, Bidar, Karnataka, 585403
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search